India · Delayed Price · Currency is INR Pfizer Statistics
Total Valuation
Pfizer has a market cap or net worth of INR 230.45 billion. The enterprise value is 204.31 billion.
| Market Cap | 230.45B |
| Enterprise Value | 204.31B |
Important Dates
The last earnings date was Monday, February 9, 2026.
| Earnings Date | Feb 9, 2026 |
| Ex-Dividend Date | Jul 9, 2025 |
Share Statistics
| Current Share Class | 45.75M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.02% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 18.15% |
| Float | 15.10M |
Valuation Ratios
The trailing PE ratio is 27.00 and the forward PE ratio is 27.37.
| PE Ratio | 27.00 |
| Forward PE | 27.37 |
| PS Ratio | 9.28 |
| PB Ratio | 5.99 |
| P/TBV Ratio | 6.98 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 23.94 |
| EV / Sales | 8.23 |
| EV / EBITDA | 22.74 |
| EV / EBIT | 24.38 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.10 |
| Debt / FCF | n/a |
| Interest Coverage | 83.30 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 51.16% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 15.53M |
| Profits Per Employee | 5.34M |
| Employee Count | 1,598 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Pfizer has paid 2.79 billion in taxes.
| Income Tax | 2.79B |
| Effective Tax Rate | 24.64% |
Stock Price Statistics
The stock price has increased by +24.36% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +24.36% |
| 50-Day Moving Average | 4,867.85 |
| 200-Day Moving Average | 5,136.83 |
| Relative Strength Index (RSI) | 59.43 |
| Average Volume (20 Days) | 4,855 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pfizer had revenue of INR 24.82 billion and earned 8.54 billion in profits. Earnings per share was 186.59.
| Revenue | 24.82B |
| Gross Profit | 16.11B |
| Operating Income | 8.38B |
| Pretax Income | 11.33B |
| Net Income | 8.54B |
| EBITDA | 8.64B |
| EBIT | 8.38B |
| Earnings Per Share (EPS) | 186.59 |
Balance Sheet
The company has 27.04 billion in cash and 898.30 million in debt, with a net cash position of 26.14 billion.
| Cash & Cash Equivalents | 27.04B |
| Total Debt | 898.30M |
| Net Cash | 26.14B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 38.48B |
| Book Value Per Share | 841.24 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 64.88%, with operating and profit margins of 33.76% and 34.39%.
| Gross Margin | 64.88% |
| Operating Margin | 33.76% |
| Pretax Margin | 45.63% |
| Profit Margin | 34.39% |
| EBITDA Margin | 34.80% |
| EBIT Margin | 33.76% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 165.00, which amounts to a dividend yield of 3.59%.
| Dividend Per Share | 165.00 |
| Dividend Yield | 3.59% |
| Dividend Growth (YoY) | 371.43% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.02% |
| Shareholder Yield | 3.62% |
| Earnings Yield | 3.70% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |